Automatic Generation of Validated Specific Epitope Sets
Open Access
- 19 October 2015
- journal article
- research article
- Published by Hindawi Limited in Clinical and Developmental Immunology
- Vol. 2015, 1-11
- https://doi.org/10.1155/2015/763461
Abstract
Accurate measurement of B and T cell responses is a valuable tool to study autoimmunity, allergies, immunity to pathogens, and host-pathogen interactions and assist in the design and evaluation of T cell vaccines and immunotherapies. In this context, it is desirable to elucidate a method to select validated reference sets of epitopes to allow detection of T and B cells. However, the ever-growing information contained in the Immune Epitope Database (IEDB) and the differences in quality and subjects studied between epitope assays make this task complicated. In this study, we develop a novel method to automatically select reference epitope sets according to a categorization system employed by the IEDB. From the sets generated, three epitope sets (EBV, mycobacteria and dengue) were experimentally validated by detection of T cell reactivity ex vivo from human donors. Furthermore, a web application that will potentially be implemented in the IEDB was created to allow users the capacity to generate customized epitope sets. Accurate measurement of B and T cell responses is a valuable tool to study autoimmunity, allergies, immunity to pathogens, and host-pathogen interactions and assist in the design and evaluation of T cell vaccines and immunotherapies. In this context, it is desirable to elucidate a method to select validated reference sets of epitopes to allow detection of T and B cells. However, the ever-growing information contained in the Immune Epitope Database (IEDB) and the differences in quality and subjects studied between epitope assays make this task complicated. In this study, we develop a novel method to automatically select reference epitope sets according to a categorization system employed by the IEDB. From the sets generated, three epitope sets (EBV, mycobacteria and dengue) were experimentally validated by detection of T cell reactivity ex vivo from human donors. Furthermore, a web application that will potentially be implemented in the IEDB was created to allow users the capacity to generate customized epitope sets.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (HHSN272201200010C, HHSN272200900044C, HHSN27220140045C, U19 AI100275)
This publication has 23 references indexed in Scilit:
- Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8 + T cellsProceedings of the National Academy of Sciences, 2013
- A Meta-Analysis of the Existing Knowledge of Immunoreactivity against Hepatitis C Virus (HCV)PLOS ONE, 2012
- Cost sensitive hierarchical document classification to triage PubMed abstracts for manual curationBMC Bioinformatics, 2011
- Towards a systems understanding of MHC class I and MHC class II antigen presentationNature Reviews Immunology, 2011
- Reverse Vaccinology: Developing Vaccines in the Era of GenomicsImmunity, 2010
- Molecular Determinants of T Cell Epitope Recognition to the Common Timothy Grass AllergenThe Journal of Immunology, 2010
- The Immune Epitope Database 2.0Nucleic Acids Research, 2009
- Classification of the Universe of Immune Epitope Literature: Representation and Knowledge GapsPLOS ONE, 2009
- One-Pot, Mix-and-Read Peptide-MHC TetramersPLOS ONE, 2008
- Celiac disease: pathogenesis of a model immunogenetic diseaseJournal of Clinical Investigation, 2007